Biotechnology
Compare Stocks
2 / 10Stock Comparison
LQDA vs MNKD
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
LQDA vs MNKD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Biotechnology |
| Market Cap | $3.66B | $1.10B |
| Revenue (TTM) | $69M | $361M |
| Net Income (TTM) | $-122M | $-24M |
| Gross Margin | 89.4% | 79.3% |
| Operating Margin | -155.0% | 4.1% |
| Forward P/E | 17.5x | 218.4x |
| Total Debt | $122M | $473M |
| Cash & Equiv. | $176M | $75M |
LQDA vs MNKD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Liquidia Corporation (LQDA) | 100 | 456.1 | +356.1% |
| MannKind Corporation (MNKD) | 100 | 235.8 | +135.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LQDA vs MNKD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LQDA is the clearest fit if your priority is long-term compounding.
- 279.6% 10Y total return vs MNKD's -46.5%
- Lower P/E (17.5x vs 218.4x)
- +171.2% vs MNKD's -25.5%
MNKD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.90
- Rev growth 22.2%, EPS growth -79.4%, 3Y rev CAGR 51.8%
- Lower volatility, beta 0.90, current ratio 1.70x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 22.2% revenue growth vs LQDA's -20.0% | |
| Value | Lower P/E (17.5x vs 218.4x) | |
| Quality / Margins | -6.6% margin vs LQDA's -176.0% | |
| Stability / Safety | Beta 0.90 vs LQDA's 1.24 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +171.2% vs MNKD's -25.5% | |
| Efficiency (ROA) | -3.9% ROA vs LQDA's -44.2%, ROIC 21.6% vs -5.0% |
LQDA vs MNKD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LQDA vs MNKD — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — LQDA and MNKD each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MNKD is the larger business by revenue, generating $361M annually — 5.2x LQDA's $69M. MNKD is the more profitable business, keeping -6.6% of every revenue dollar as net income compared to LQDA's -176.0%. On growth, LQDA holds the edge at +11.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $69M | $361M |
| EBITDAEarnings before interest/tax | -$106M | $25M |
| Net IncomeAfter-tax profit | -$122M | -$24M |
| Free Cash FlowCash after capex | -$108M | $13M |
| Gross MarginGross profit ÷ Revenue | +89.4% | +79.3% |
| Operating MarginEBIT ÷ Revenue | -155.0% | +4.1% |
| Net MarginNet income ÷ Revenue | -176.0% | -6.6% |
| FCF MarginFCF ÷ Revenue | -155.8% | +3.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.2% | +15.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +86.4% | -2.2% |
Valuation Metrics
LQDA leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.7B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -25.39x | 178.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.48x | 218.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 29.32x |
| Price / SalesMarket cap ÷ Revenue | 261.40x | 3.15x |
| Price / BookPrice ÷ Book value/share | 42.92x | — |
| Price / FCFMarket cap ÷ FCF | — | 80.31x |
Profitability & Efficiency
MNKD leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), MNKD scores 4/9 vs LQDA's 1/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -5.5% | — |
| ROA (TTM)Return on assets | -44.2% | -3.9% |
| ROICReturn on invested capital | -5.0% | +21.6% |
| ROCEReturn on capital employed | -84.1% | +8.3% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 |
| Debt / EquityFinancial leverage | 1.58x | — |
| Net DebtTotal debt minus cash | -$54M | $399M |
| Cash & Equiv.Liquid assets | $176M | $75M |
| Total DebtShort + long-term debt | $122M | $473M |
| Interest CoverageEBIT ÷ Interest expense | -4.63x | 0.75x |
Total Returns (Dividends Reinvested)
LQDA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LQDA five years ago would be worth $165,255 today (with dividends reinvested), compared to $8,725 for MNKD. Over the past 12 months, LQDA leads with a +171.2% total return vs MNKD's -25.5%. The 3-year compound annual growth rate (CAGR) favors LQDA at 77.0% vs MNKD's -2.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +34.2% | -36.4% |
| 1-Year ReturnPast 12 months | +171.2% | -25.5% |
| 3-Year ReturnCumulative with dividends | +454.5% | -8.2% |
| 5-Year ReturnCumulative with dividends | +1552.5% | -12.7% |
| 10-Year ReturnCumulative with dividends | +279.6% | -46.5% |
| CAGR (3Y)Annualised 3-year return | +77.0% | -2.8% |
Risk & Volatility
Evenly matched — LQDA and MNKD each lead in 1 of 2 comparable metrics.
Risk & Volatility
MNKD is the less volatile stock with a 0.90 beta — it tends to amplify market swings less than LQDA's 1.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LQDA currently trades 90.3% from its 52-week high vs MNKD's 54.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.24x | 0.90x |
| 52-Week HighHighest price in past year | $46.67 | $6.51 |
| 52-Week LowLowest price in past year | $11.85 | $2.23 |
| % of 52W HighCurrent price vs 52-week peak | +90.3% | +54.7% |
| RSI (14)Momentum oscillator 0–100 | 59.2 | 53.6 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 6.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates LQDA as "Buy" and MNKD as "Buy". Consensus price targets imply 96.6% upside for MNKD (target: $7) vs 20.2% for LQDA (target: $51).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $50.67 | $7.00 |
| # AnalystsCovering analysts | 7 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
LQDA leads in 2 of 6 categories (Valuation Metrics, Total Returns). MNKD leads in 1 (Profitability & Efficiency). 2 tied.
LQDA vs MNKD: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is LQDA or MNKD a better buy right now?
For growth investors, MannKind Corporation (MNKD) is the stronger pick with 22.
2% revenue growth year-over-year, versus -20. 0% for Liquidia Corporation (LQDA). MannKind Corporation (MNKD) offers the better valuation at 178. 0x trailing P/E (218. 4x forward), making it the more compelling value choice. Analysts rate Liquidia Corporation (LQDA) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LQDA or MNKD?
On forward P/E, Liquidia Corporation is actually cheaper at 17.
5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — LQDA or MNKD?
Over the past 5 years, Liquidia Corporation (LQDA) delivered a total return of +1553%, compared to -12.
7% for MannKind Corporation (MNKD). Over 10 years, the gap is even starker: LQDA returned +279. 6% versus MNKD's -46. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LQDA or MNKD?
By beta (market sensitivity over 5 years), MannKind Corporation (MNKD) is the lower-risk stock at 0.
90β versus Liquidia Corporation's 1. 24β — meaning LQDA is approximately 38% more volatile than MNKD relative to the S&P 500.
05Which is growing faster — LQDA or MNKD?
By revenue growth (latest reported year), MannKind Corporation (MNKD) is pulling ahead at 22.
2% versus -20. 0% for Liquidia Corporation (LQDA). On earnings-per-share growth, the picture is similar: Liquidia Corporation grew EPS -37. 2% year-over-year, compared to -79. 4% for MannKind Corporation. Over a 3-year CAGR, MNKD leads at 51. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LQDA or MNKD?
MannKind Corporation (MNKD) is the more profitable company, earning 1.
7% net margin versus -931. 7% for Liquidia Corporation — meaning it keeps 1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MNKD leads at 11. 1% versus -866. 6% for LQDA. At the gross margin level — before operating expenses — MNKD leads at 82. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LQDA or MNKD more undervalued right now?
On forward earnings alone, Liquidia Corporation (LQDA) trades at 17.
5x forward P/E versus 218. 4x for MannKind Corporation — 200. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MNKD: 96. 6% to $7. 00.
08Which pays a better dividend — LQDA or MNKD?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is LQDA or MNKD better for a retirement portfolio?
For long-horizon retirement investors, MannKind Corporation (MNKD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
90)). Both have compounded well over 10 years (MNKD: -46. 5%, LQDA: +279. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LQDA and MNKD?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: LQDA is a small-cap quality compounder stock; MNKD is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.